Transfusion Support for Moderate and Severe Cases of COVID-19

被引:0
|
作者
Walker, L. [1 ]
Wickenheiser, Z. [1 ]
机构
[1] Univ Texas Med Branch, Galveston, TX USA
关键词
D O I
10.1111/trf.429_17554
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P-TS-92
引用
下载
收藏
页码:317A / 318A
页数:2
相关论文
共 50 条
  • [21] Neurological manifestations in mild and moderate cases of COVID-19
    Ghada Saed Abdel Azim
    Marwa Abdellah Osman
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57
  • [22] Neurological manifestations in mild and moderate cases of COVID-19
    Azim, Ghada Saed Abdel
    Osman, Marwa Abdellah
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01):
  • [23] Comparison Between Body Composition And Cardiorespiratory Fitness Of Covid-19 Survivors In Moderate And Severe Cases
    Magnani Branco, Braulio H.
    Lemos, Mauricio M.
    Cavalini, Gustavo R.
    Pugliese Henrique, Carlos R.
    Marchiori, Gloria M.
    Moraes Marchiori, Luciana L.
    Ramos, Solange P.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2022, 54 (09) : 145 - 145
  • [24] COVID-19 vaccination benefits in preventing severe disease in mild-to-moderate cases: An analysis in the first specialized hospital for COVID-19 in Japan
    Kobayashi, Masanori
    Miyamoto, Atsushi
    Watanabe, Tetsuya
    Sawa, Kenji
    Sato, Kanako
    Yamada, Kazuhiro
    Yoshii, Naoko
    Yamada, Koichi
    Kawamoto, Kengo
    Uji, Masato
    Shiraishi, Satoshi
    Asai, Kazuhisa
    Kakeya, Hiroshi
    Kawaguchi, Tomoya
    RESPIRATORY INVESTIGATION, 2023, 61 (02) : 230 - 239
  • [25] Continuous Remote Monitoring in Moderate and Severe COVID-19 Patients
    Rajanna, Avinash H.
    Bellary, Vaibhav S.
    Puranic, Sohani Kashi
    Nayana, C.
    Nagaraj, Jatin Raaghava
    Eshanye, D. A.
    Preethi, K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [26] Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
    Reid, Nancy Kierstin
    Joyner, Kayla Rena
    Lewis-Wolfson, Temeka Dawn
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (07) : 769 - 775
  • [27] BARICITINIB VERSUS TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19
    Lewis-Wolfson, Temeka
    Joyner, Kayla
    Reid, Nancy
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 191 - 191
  • [28] The State of Microcirculatory Hemodynamics in Patients with Moderate and Severe COVID-19
    Kuznik, B., I
    Smolyakov, Yu N.
    Shapovalov, Yu K.
    Shapovalov, K. G.
    Lukyanov, S. A.
    Parts, D. S.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 171 (04) : 453 - 457
  • [29] Clinical characteristics of Japanese patients with moderate to severe COVID-19
    Otoshi, Ryota
    Hagiwara, Eri
    Kitayama, Takaaki
    Yamaya, Takafumi
    Higa, Katsuyuki
    Murohashi, Kota
    Sato, Yozo
    Tabata, Erina
    Shintani, Ryota
    Okabayashi, Hiroko
    Ikeda, Satoshi
    Niwa, Takashi
    Nakazawa, Atsuhito
    Oda, Tsuneyuki
    Okuda, Ryo
    Sekine, Akiamasa
    Kitamura, Hideya
    Baba, Tomohisa
    Komatsu, Shigeru
    Ogura, Takashi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (06) : 895 - 901
  • [30] Cytokine Storm Signature in Patients with Moderate and Severe COVID-19
    Kalinina, Olga
    Golovkin, Alexey
    Zaikova, Ekaterina
    Aquino, Arthur
    Bezrukikh, Vadim
    Melnik, Olesya
    Vasilieva, Elena
    Karonova, Tatiana
    Kudryavtsev, Igor
    Shlyakhto, Evgeny
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)